US FDA Approves At-home Use Of BioXcel's Agitation Drug
Summary
The US Food and Drug Administration on Monday approved at-home use of BioXcel Therapeutics' drug, Igalmi, for agitation associated with schizophrenia or bipolar... Reuters Health Information
Description from Medscape.
Who is covering this
-
US FDA Approves At-home Use Of BioXcel's Agitation Drug
The US Food and Drug Administration on Monday approved at-home use of BioXcel Therapeutics' drug, Igalmi, for agitation associated with schizophrenia or bipolar... Reuters Health Information






Comments
Comments need JavaScript.